Skip to content
Screener

Baxter International BAX Pharmaceuticals — Currency translation

Other segment segments

Medical Products & Therapies
-$17M-145%
Healthcare Systems & Technologies
-$5M-163%

Similar metrics at other companies

Dick's Sporting Goods logo
DKSDICK’S — Currency translation
$0—
Kontoor Brands, Inc. logo
KTBLee — Currency translation
$38K+137%
Kontoor Brands, Inc. logo
KTBOther — Currency translation
$136K+2,167%
Kontoor Brands, Inc. logo
KTBWrangler — Currency translation
-$435K-810%
Mueller Industries logo
MLIClimate — Currency translation
$0—
Haemonetics logo
HAEApheresis — Currency translation
-$22K—

Other financials

Income statement

See full
Revenue$2.7B+2.9%
Gross profit$891.0M+3.5%
Operating income$66.0M+13.8%
Net income-$15.0M-112%
EPS (diluted)-$0.03-112%

Balance sheet

See full
Cash & equivalents$2.0B-12.1%
Total debt$224.0M-8.9%
Total equity$6.0B-14.7%
Total assets$19.8B-6.8%

Cash flow

See full
Operating cash flow$213.0M+210%
CapEx$128.3M+15.0%
Free cash flow$83.0M-42.1%

Valuation

See full
Market cap$14.13B+22.3%
Enterprise value$12.33B+22.1%
P/S1.3×+0.2×

Profitability

See full
Gross margin30.1%-5.9pp
Operating margin-2.7%—
Net margin-9.7%+62.5pp
FCF margin3%-2.4pp

Returns & leverage

See full
Return on equity-16.7%-76.7pp
Debt / equity0×0.0×
Current ratio1.9×-0.2×

Where this comes from

Reported directly by Baxter International in its filing.

Tagged under the XBRL concept us-gaap:GoodwillForeignCurrencyTranslationGainLoss.

The source filing: Baxter International’s 10-Q, filed April 30, 2026.

Filed
Apr 30, 2026, 4:50 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001628280-26-028962
(in millions)Medical Products & TherapiesHealthcare Systems & TechnologiesPharmaceuticalsTotal
Balance as of December 31, 2025$1,265$3,087$577$4,929
Currency translation(17)(5)(8)(30)
Balance as of March 31, 2026$1,248$3,082$569$4,899

Item 1. Financial Statements (unaudited)

FAQ

What is Baxter International's pharmaceuticals — currency translation?
Baxter International (BAX) reported pharmaceuticals — currency translation of -$8M in Q1 2026.
How has Baxter International's pharmaceuticals — currency translation changed year-over-year?
Baxter International's pharmaceuticals — currency translation decreased by 147.1% year-over-year, from $17M to -$8M.
What does pharmaceuticals — currency translation mean?
Captures the impact of fluctuations in foreign exchange rates on the financial results of the Pharmaceuticals segment. This metric adjusts for the variance between the functional currency of international operations and the reporting currency of the parent company.

Ask your AI about Baxter International's pharmaceuticals — currency translation.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude